Skip to main content
Equibles
TMDX logo

TMDX · TransMedics Group, Inc.

Track TMDX — free

Use TMDX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$89.98 +3.00 (+3.45%) At close · Sep 4
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$3.02B
Shares
34.68M

TMDX metrics

73 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$89.98
Market cap
$3.02B

Price action

19 metrics
Price change (1W)
+1.8%
Price change (30D)
+12.2%
Price change (3M)
+29.6%
Price change (6M)
-30.6%
Price change (YTD)
-26.0%
Price change (1Y)
-13.5%
Trailing year
Price change (5Y)
+175.4%
52-week high
$150.42
52-week low
$62.04
Change from 52-week high
-40.2%
Change from 52-week low
+45.0%
Annualized volatility
57.4%
Beta
1.2
RSI (14D)
56.6
Price vs SMA 50
+12.3%
Price vs SMA 200
-14.1%
Avg volume (3M)
938,079
Relative volume
0.6
Average dollar volume
$72.70M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
34.68M

Valuation

12 metrics
P / E (TTM)
23.3
Trailing earnings · reciprocal yield 4.3%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.5×
reciprocal yield 22.2%
P / book
5.8
reciprocal yield 17.2%
FCF yield
2.6%
TTM · current market cap
Buyback yield
—
P / FCF
38.2
reciprocal yield 2.6%
P / operating cash flow
20.7
reciprocal yield 4.8%
Earnings yield
5.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
58.7%
Operating margin
12.2%
Trailing 12 months
Net margin
22.7%
Gross profit (TTM)
$392.35M
Operating profit (TTM)
$81.61M
Net income (TTM)
$151.70M
Trailing 12 months
Diluted EPS (TTM)
$3.86
FCF margin
11.8%
Effective tax rate
-109.1%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$6.25

Growth

11 metrics
Revenue growth YoY
+20.7%
Year over year
Net income growth YoY
-57.9%
Revenue (TTM)
$668.47M
Trailing 12 months
EPS growth YoY
-55.4%
Shares change YoY
+0.4%
Year over year · more shares
Revenue CAGR (3Y)
+86.4%
Revenue CAGR (5Y)
+88.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
29.3%
Return on assets
10.4%
Debt / equity
—
Current ratio
6.6
EBITDA (TTM)
$118.03M
Free cash flow (TTM)
$79.04M
Quick ratio
6.1
Interest coverage
3.8
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$491.11M
Total assets
$1.46B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$145.93M
Capital expenditures (TTM)
$66.89M
R&D (TTM)
$92.47M
SG&A (TTM)
$218.27M
Stock compensation (TTM)
$37.09M
R&D / revenue
13.8%
Stock compensation / revenue
5.5%

Ownership (13F)

3 metrics
13F filers
379
13F filer change QoQ
-42
Institutional ownership
108.9%

Short interest

3 metrics
Short interest
22.8%
Latest settlement · 6.7 days to cover
Days to cover
6.7d
Short-squeeze score
78 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$722,377
Insider-sentiment score
40 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1756262 CUSIP 89377M109 13F (30d) 253 filings 251 filers Visit website Investor relations